Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-06-07 6:29 pm Purchase | 13D | PASITHEA THERAPEUTICS CORP COM KTTA | STEINMAN LAWRENCE | 1,577,174 6.000% | 1,577,174 (New Position) | View |
2023-02-14 6:28 pm Unchanged | 13G | PASITHEA THERAPEUTICS CORP COM KTTA | Manning Paul B | 3,408,696 11.300% | 0 (Unchanged) | View |
2023-01-13 08:02 am Sale | 13G | PASITHEA THERAPEUTICS CORP COM KTTA | Khire Uday | 1,228,108 4.600% | -244,554 (-16.61%) | View |
2023-01-10 3:55 pm Sale | 13D | PASITHEA THERAPEUTICS CORP COM KTTA | Camac Fund LP | 0 0.000% | -1,788,415 (Position Closed) | View |
2022-12-13 7:26 pm Unchanged | 13D | PASITHEA THERAPEUTICS CORP COM KTTA | Camac Fund LP | 1,788,415 6.100% | 0 (Unchanged) | View |
2022-11-01 5:28 pm Purchase | 13D | PASITHEA THERAPEUTICS CORP COM KTTA | Camac Fund LP | 1,788,415 6.700% | 86,105 (+5.06%) | View |
2022-10-20 11:11 am Purchase | 13G | PASITHEA THERAPEUTICS CORP COM KTTA | Khire Uday | 1,472,662 5.000% | 1,472,662 (New Position) | View |
2022-09-06 4:10 pm Purchase | 13D | PASITHEA THERAPEUTICS CORP COM KTTA | Camac Fund LP | 1,702,310 6.400% | 67,153 (+4.11%) | View |
2022-09-01 06:05 am Purchase | 13D | PASITHEA THERAPEUTICS CORP COM KTTA | Camac Fund LP | 1,635,157 6.100% | 179,601 (+12.34%) | View |
2022-08-11 10:26 am Purchase | 13D | PASITHEA THERAPEUTICS CORP COM KTTA | Camac Fund LP | 1,455,556 5.500% | 288,821 (+24.75%) | View |
2022-07-27 9:45 pm Purchase | 13D | PASITHEA THERAPEUTICS CORP COM KTTA | Camac Fund LP | 1,166,735 4.400% | 132,033 (+12.76%) | View |
2022-06-29 4:30 pm Purchase | 13G | PASITHEA THERAPEUTICS CORP COM KTTA | Manning Paul B | 3,408,696 9.800% | 3,408,696 (New Position) | View |
2022-06-24 6:16 pm Unchanged | 13D | PASITHEA THERAPEUTICS CORP COM KTTA | Camac Fund LP | 1,034,702 4.400% | 0 (Unchanged) | View |
2022-06-16 10:29 am Unchanged | 13D | PASITHEA THERAPEUTICS CORP COM KTTA | Camac Fund LP | 1,034,702 4.400% | 0 (Unchanged) | View |
2022-06-01 10:08 am Purchase | 13D | PASITHEA THERAPEUTICS CORP COM KTTA | Camac Fund LP | 1,034,702 4.400% | 1,034,702 (New Position) | View |
2022-02-03 3:53 pm Purchase | 13G | PASITHEA THERAPEUTICS CORP COM KTTA | Ionic Ventures LLC | 870,265 2.850% | 113,591 (+15.01%) | View |
2022-01-31 6:21 pm Sale | 13G | PASITHEA THERAPEUTICS CORP COM KTTA | K2 PRINCIPAL FUND L.P. | 1,094,418 4.990% | -605,582 (-35.62%) | View |
2022-01-13 10:56 am Sale | 13G | PASITHEA THERAPEUTICS CORP COM KTTA | ALPHA CAPITAL ANSTALT | 715,000 3.267% | -116,755 (-14.04%) | View |
2021-12-20 4:00 pm Purchase | 13G | PASITHEA THERAPEUTICS CORP COM KTTA | K2 PRINCIPAL FUND L.P. | 1,700,000 7.480% | 1,700,000 (New Position) | View |
2021-11-04 4:02 pm Purchase | 13G | PASITHEA THERAPEUTICS CORP COM KTTA | ALPHA CAPITAL ANSTALT | 831,755 6.360% | 831,755 (New Position) | View |